Following an increasing number of studies, two new reviews have described treatment with platelet-rich plasma in POI patients as encouraging, but raise questions over the methodology of these studies and how platelet activation might work in the ovary.
Focus on Reproductions first mention of platelet-rich plasma for ovarian rejuvenation came in September 2016 following presentation of a poster at that years annual meeting in Helsinki. A group from Athens had described ovarian rejuvenation and folliculogenesis reactivation in eight menopausal women who were all without menstrual cycles for around five years. Following infusion of the plasma, described as a concentrated source of growth factors and cytokines, menstrual cycles seemed restored after some three months and oocyte retrieval successful in all cases.
Since then, and alongside occasional interest in the popular press, there have been further study reports, several clinics advertising treatment, and now two reviews in scientific journals.(1,2) But even before this interest in reproduction and the restoration of fertility in POI, platelet-rich plasma had been claimed to encourage tissue healing and repair (including hair regrowth), with its most common applications in sports injuries (particularly knees) and arthritis. Golfer Tiger Woods reportedly used PRP to help repair his damaged Achilles tendon in 2010.
Most recently, however, a study from Taiwan in 12 women diagnosed with POI and whose ovaries were injected with a combination of autologous PRP and FSH, has reported fertilisation of the retrieved oocytes and ongoing pregnancies.(3) Weekly ultrasound scanning of the 12 women - all aged 40-50 years with amenorrhea for more than a year - eventually revealed that 11 resumed their menstrual cycle over a mean period of five weeks, most of which were irregular.
In their conclusion the authors reported that PRP with gonadotrophins could increase the probability of pregnancy using autologous oocytes in women with early menopause. The report indicates that 13 mature eggs were retrieved in total, which were then fertilised by ICSI. Two subjects had cleavage stage embryos transferred, one of whom achieved a clinical pregnancy (with one live birth reported elsewhere).(4)
This is just one of several uncontrolled studies on PRP in ovarian rejuvenation, all of which (up to 2020) are listed in fine detail (findings, procedure, controls) by Atkinson et al in their mini review for Human Reproduction. Notable among them is an update from the Athens group reporting data from a total of 120 patients in four pilot studies on poor response in IVF, POI, perimenopause and menopause.(5) With results varying somewhat in each of the pilot studies, the authors reported a significant improvement on the hormonal profile and the ovarian reserve status . . . along with improved intracytoplasmic sperm injection (ICSI) cycle performance concerning POR [poor ovarian response] participants. Such studies are increasing in number, and are described in the HR review as encouraging, although with the caveat that a properly controlled randomised clinical trial will be necessary to confirm the efficacy of ovarian PRP therapy.
Do the results have biological plausibility? Should we take them seriously? Rosario and Anderson describe PRP as a preparation of autologous human plasma with an increased platelet concentration produced by centrifuging a large volume of a patients own blood, which concentrates the multitude of growth factors and cytokines produced by platelets. Evidence is apparently strong that platelets do release a range of cytokines in response to activation, and, say the HR reviewers, cytokine signalling is increasingly apparent in the interrelationships between the oocyte and granulosa and thecal cells. Any dysfunction in this system, they add, results in deficiencies in follicle maturation, ovulation and luteinisation. So one working hypothesis is that PRP may well provide a readily accessible, individualised, cost-effective blend of proangiogenic, proliferative and proinflammatory factors which may stimulate de-novo oogenesis and/or follicle maturation.
In their review of novel approaches to fertility restoration Rosario and Anderson list PRP therapy alongside other means of activating residual primordial follicles in women with POI - for example, when treated with mesenchymal stem cells extracted from bone marrow, placenta and menstrual blood. However, they too note that much of the clinical data so far are derived from studies of PRP infusion.
It's worth noting that the HR review ends with a note of caution. Singled out from the studies reported so far are their lack of control and details of the mechanism of how PRP via platelet activation might work on the ovary. Despite the autologous source of PRP, the latter question is emphasised as a major reason for caution and a need for fundamental research at the cellular level. Dysregulation of early processes in oocyte maturation and subsequent embryo development can lead to drastic changes in the growing foetus, the authors warn, possibly leading to increased risk of disease in early years and onwards.
Back in 2016 and with our first mention of ovarian rejuvenation, the popular press headlines would then signal the end of the menopause, bringing to mind the same speculation raised by Jonathan Tilly and his discovery of egg precursor cells.(6) A few years later a non-peer reviewed paper described improved IVF results in poor prognosis patients following the transfer of mitochondria derived from these same autologous egg precursor cells. That first discovery of Tilly was also publicly presented as the demise of the menopause, but that concept appeared to fail for want of controlled studies and reproducible results. PRP, it seems from the caveats now reported in these two recent reviews, will also need the evidence of robust studies for its further progress.
* One of the two keynote lectures set to open this years ESHRE annual meeting will be from Antonio Pellicer, co-editor of Fertility and Sterility, on Expanding the ovarys reproductive lifespan: Preservation and Rejuvenation.
1. Atkinson A, Martin F, Sturmey RG. Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon? Hum Reprod 2021; doi:10.1093/humrep/deab1062. Rosario R, Anderson RA. Novel approaches to fertility restoration in women with premature ovarian insuffiency. Climacteric 2021; doi:10.1080/13697137.2020.18568063. Chao Chin H, Hsu I, Hsu L, et al. Resumed ovarian function and pregnancy in early menopausal women by whole dimension subcortical ovarian administration of platelet-rich plasma and gonadotropins. Menopause 2021; doi:10.1097/GME.0000000000001746.4. Hsu CC, Hsu L, Hsu I, et al. Live birth in woman with premature ovarian insufficiency receiving ovarian administration of platelet-rich plasma (PRP) in combination with gonadotropin: a case report. Front Endocrinol 2020; 11: 50. doi:10.3389/fendo.2020.000505. Sfakianoudis K, Simopoulou M, Grigoriadis S, et al. Reactivating ovarian function through autologous platelet-rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency, perimenopausal, menopausal, and poor responder women. J Clin Med 2020; 9: 1809. doi:10.3390/jcm9061809.6. Johnson J, Canning J, Kaneko T, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004; 428: 145-150.
follicular activationpremature ovarian failureovarian rejuvenationplatelet rich plasma
Visit link:
Platelet-rich plasma and the restoration of fertility in POI - ESHRE
- Mesenchymal stem cell based therapies for uveitis: a systematic review of preclinical studies | Eye - Nature.com - April 10th, 2024
- Development of exosome therapy to treat inflammatory bowel disease by VesiCURE Therapeutics - StreetInsider.com - April 10th, 2024
- Adipose Derived Stem Cell Therapy Market Will Show the Highest Growth Rates, Incredible Demand by 2031 - WhaTech - April 3rd, 2024
- Injectable microspheres adhering to the cartilage matrix promote rapid reconstruction of partial-thickness cartilage defects - ScienceDirect.com - March 30th, 2024
- Safety and Potential Effect of Intrauterine Infusion of Autologous Adipose Tissue-Derived Regenerative Cells in ... - Cureus - March 30th, 2024
- Instructing iPS cell-derived mesenchymal stem cells to inhibit abnormal bone formation in FOP - Medical Xpress - March 28th, 2024
- Clinical application of mesenchymal stem cell in regenerative medicine ... - March 22nd, 2024
- Mesenchymal Stem Cells: The Past Present and Future - March 22nd, 2024
- CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General ... - Yahoo Finance - March 20th, 2024
- Overexpression of Wnt5a promoted the protective effect of mesenchymal stem cells on Lipopolysaccharide-induced ... - BMC Infectious Diseases - March 20th, 2024
- Mesenchymal Stem Cells: What We Have Learned and How to Manage Them - MDPI - March 17th, 2024
- Mesenchymal stem cells and their microenvironment - March 17th, 2024
- Mesenchymal stem/stromal cells as a valuable source for the treatment ... - March 17th, 2024
- Proteomic characterization of hUC-MSC extracellular vesicles and evaluation of its therapeutic potential to treat ... - Nature.com - March 13th, 2024
- The impact understanding of exosome therapy in COVID-19 and preparations for the future approaches in dealing with ... - Nature.com - March 13th, 2024
- CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to ... - Yahoo Finance UK - March 7th, 2024
- CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to ... - Yahoo Finance - March 6th, 2024
- Combatting osteoarthritis with cartilage replacement therapy - Drug Target Review - March 3rd, 2024
- Ethical considerations in Stem Cell therapy for ALS - Cyprus Mail - February 27th, 2024
- Therapeutic Solutions International Files Patent on Facilitating Effects of JadiCells on Gene Therapy Mediated Cell ... - Business Wire - February 27th, 2024
- Stem Cell Therapy for Ulcerative Colitis - Health Central - February 27th, 2024
- Expanding the Horizons of Cell and Gene Therapy - RegMedNet - February 24th, 2024
- Early differentiation of mesenchymal stem cells is reflected in their dielectrophoretic behavior | Scientific Reports - Nature.com - February 22nd, 2024
- Orthopaedics Department's Regenerative Research Highlighted at ORS Annual Meeting - InventUM - University of Miami - February 20th, 2024
- Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona ... - Nature.com - February 18th, 2024
- New University spin-out developing novel adult stem cell-based Therapies - News - University of Liverpool - News - February 15th, 2024
- Examining the potential of the common bovine as a potential therapeutic research model - Medical Xpress - February 15th, 2024
- Intentional Interference: Genetic Engineering Medium Aids The Transfection Of MSCs With siRNA - BioProcess Online - February 15th, 2024
- Cellular senescence is associated with osteonecrosis of the femoral head while mesenchymal stem cell conditioned ... - Nature.com - February 9th, 2024
- Stem Cell Therapy for Crohns Disease Shows Promising Results - RegMedNet - February 9th, 2024
- Targeted transcriptomic analysis of synovial tissues from horses with septic arthritis treated with immune-activated ... - American Veterinary Medical... - February 7th, 2024
- Mesenchymal Stem Cell Immunomodulation: Mechanisms and ... - Cell Press - February 7th, 2024
- New Cell Therapy for ARDS: A Groundbreaking Development and Other Respiratory Health Breakthroughs - Medriva - February 7th, 2024
- Effective treatment of optic neuropathies by intraocular delivery of MSC-sEVs through augmenting the G-CSF ... - pnas.org - January 31st, 2024
- Global Stem Cell Therapy Industry Outlook to 2028, Driven by Therapeutic Innovations and Clinical Advancements ... - Yahoo Finance - January 29th, 2024
- Out-of-this-world study will test how stem cells function in space - YP - January 29th, 2024
- The Applications of Cell Therapy - Technology Networks - January 26th, 2024
- STEM CELL THERAPY FOR MS COST: WHAT YOU NEED TO KNOW? - Island Echo - January 24th, 2024
- Understanding Neuromyelitis Optica: Role of NF-B and Therapeutic Potential - Medriva - January 20th, 2024
- Faculty member Arnold Caplan passes away The Daily The Daily - The Daily | Case Western Reserve University - January 18th, 2024
- Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic ... - Nature.com - January 11th, 2024
- Expression of HLA-DR by mesenchymal stromal cells in the platelet lysate era: an obsolete release criterion for MSCs ... - Journal of Translational... - January 11th, 2024
- NurOwn and its exosomes for ALS given patents in Europe, elsewhere - ALS News Today - January 8th, 2024
- Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian ... - Nature.com - January 8th, 2024
- First in Class Combination Stem Cell and Exosome Therapy to Treat Pulmonary Fibrosis in Long Haul Covid Patients ... - Yahoo Finance - January 4th, 2024
- Choosing the Right Excipients for MSC and iPSC Therapies - Pharmaceutical Technology Magazine - January 4th, 2024
- Mitochondria Transplantation Therapy It's Farther Along Than You Think - BioProcess Online - January 2nd, 2024
- Embryonic-stem-cell-derived mesenchymal stem cells relieve experimental contact urticaria by regulating the functions ... - Nature.com - December 21st, 2023
- Type I collagen and fibromodulin enhance the tenogenic phenotype of hASCs and their potential for tendon ... - Nature.com - December 19th, 2023
- Could the 'central dogma' of biology be misleading bioengineers? - Phys.org - December 13th, 2023
- The Risks of Stem Cell and Exosome Treatments for Long COVID: A Call for Stricter Regulations - Medriva - December 13th, 2023
- Mesenchymal stem cells from biology to therapy - PMC - December 11th, 2023
- The Safety and Efficacy of Human Umbilical Cord-Derived ... - Cureus - December 5th, 2023
- The pivotal role of Nrf2 signal axis in IDD | JIR - Dove Medical Press - December 5th, 2023
- Futuristic Novel Therapeutic Approaches in the Treatment of ... - Cureus - December 3rd, 2023
- Cartilage's Contribution in Otology: A Comprehensive Review of Its ... - Cureus - December 3rd, 2023
- Mesenchymal stem or stromal cells: a review of clinical applications ... - November 29th, 2023
- Comparative evaluation of 3D-printed and conventional implants in ... - Nature.com - November 29th, 2023
- Expression of E-cadherin and N-cadherin in Epithelial-to ... - Cureus - November 29th, 2023
- Enhancing the immunosuppressive properties of human umbilical cord mesenchymal stem cells - Phys.org - November 29th, 2023
- 'Great Potential' in Stem Cell Therapies for Knee Osteoarthritis ... - Pain News Network - November 25th, 2023
- Dietary Sources, Bioavailability, and Functions of Ascorbic Acid ... - Cureus - November 25th, 2023
- FY 2024 VA-Funded Projects - VA's Office of Research and Development - November 25th, 2023
- Real-world data suggest effectiveness of the allogeneic ... - Journal of Translational Medicine - November 23rd, 2023
- Mesenchymal Stem Cells: Characteristics, Function, and Application - November 23rd, 2023
- Combined application of therapeutic viruses and nanomaterials to ... - News-Medical.Net - November 23rd, 2023
- Progress in the Development of Stem Cell-Derived Cell-Free ... - Dove Medical Press - November 23rd, 2023
- Improving the therapeutic efficacy of oncolytic viruses for cancer ... - Journal of Translational Medicine - November 23rd, 2023
- 11.22.23 -- How To Lose A Batch In 10 Days - BioProcess Online - November 23rd, 2023
- The Pros and Cons of Mesenchymal Stem Cell-Based Therapies - November 19th, 2023
- Leptin's influence on MMP-1 expression | JIR - Dove Medical Press - November 15th, 2023
- TWIST1 and TSG6 are coordinately regulated and function as ... - Science - November 11th, 2023
- Association between severe acute malnutrition in childhood and ... - BioMed Central - November 11th, 2023
- Global Market for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Yahoo Finance - November 11th, 2023
- Stem Cell Restore Reviews - Does It Work? Real Green Valley ... - The Daily World - November 11th, 2023
- Biological and genetic characterization of a newly established ... - Nature.com - November 11th, 2023
- Placental Stem Cell Collection and Storage Industry Scope ... - Argyle Report - November 9th, 2023
- In Vitro Evaluation of Light-Induced Cytotoxic Property: Synergistic ... - Cureus - November 9th, 2023
- UF professor launches nonprofit to equalize cell-based therapy access - Mainstreet Daily News Gainesville - November 7th, 2023
- Who are the leading innovators in cell immunomodulation for the ... - Pharmaceutical Technology - November 7th, 2023
Recent Comments